Robert Bradley Lindell

faculty photo
Assistant Professor of Anesthesiology and Critical Care at the Hospital of the University of Pennsylvania and the Children's Hospital of Philadelphia
Attending Physician, Division of Critical Care Medicine, Children's Hospital of Philadelphia
Member, Institute for Immunology & Immune Health, University of Pennsylvania Perelman School of Medicine
Member, Institute for Translational Medicine & Therapeutics, University of Pennsylvania Perelman School of Medicine
Member, Institute for Immunology & Immune Health, Section on Precision Immunology, University of Pennsylvania Perelman School of Medicine
Department: Anesthesiology and Critical Care

Contact information
Children’s Hospital of Philadelphia
Department of Anesthesiology and Critical Care Medicine
3401 Civic Center Boulevard
Philadelphia, PA 19104
Education:
BA (Religion)
University of Georgia, 2007.
BS (Microbiology)
University of Georgia, 2007.
MD (Medicine)
Vanderbilt University School of Medicine, 2012.
Post-Graduate Training
Resident, General Pediatrics, Children's Hospital of Philadelphia, 2012-2015.
Fellow, Pediatric Critical Care Medicine, Children's Hospital of Philadelphia, 2016-2019.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Itmat Expertise

As a pediatric intensivist, I care for critically ill children across a wide spectrum of ages and underlying pathologies. My clinical and translational research efforts are focused on enhancing our understanding of the immunobiology of pediatric sepsis, particularly in immunocompromised children.

Selected Publications

Stormes B, Brunetti MA, Parrish BT, Lindell RB, Himebauch A, Fitzgerald JC : Outcomes of Pediatric Cardiac ICU Patients With Intracranial Hemorrhage on ECMO. Society of Critical Care Medicine January 2024 Notes: SCCM Congress 2024 - Research Snapshot.

Lenz KB, Nishisaki A, Lindell RB, Yehya N, Laverriere EK, Bruins BB, Napolitano N, Traynor DM, Rowan CM, Fitzgerald JC: Peri-Intubation Adverse Events in the Critically Ill Child After Hematopoietic Cell Transplant. Pediatric Critical Care Medicine 24(7): 584-593, July 2023.

Lindell RB: The use and duration of preintubation respiratory support in immunocompromised children. Virtual Pediatric Systems Research Spotlight Webinar Series May 2023.

Lindell RB, Meyer NJ: Interrogating the sepsis host response using cytomics. Crit Care 27(1), Mar 2023.

Nguyen J, Thompson JM, Balcarcel DR, Wong HR, Alder MN, McKeone DJ, Halstead ES, Rowan CM, Lindell RB, Yehya N: Immunocompromised children with ARDS possess a distinct circulating inflammatory profile. Crit Care Explor 5(1): e0844, Jan 2023.

Nguyen J, Thompson JM, Balcarcel DR, Wong HR, Alder MN, McKeone DJ, Halstead ES, Rowan CM, Lindell RB, Yehya N: Immunocompromised Children With ARDS Possess a Distinct Circulating Inflammatory Profile. Society of Critical Care Medicine Annual Congress, San Francisco, CA January 2023.

Lindell RB, Meyer NJ: Interrogating the sepsis host response using cytomics (textbook chapter). Annual Update in Intensive Care and Emergency Medicine 2023. Vincent J-L (eds.). Springer, Page: 39-48, 2023.

Tabone A, Kozyak B, Lindell RB, Himebauch A, Hager A: The Utilization of Angiotensin II in Calcium Channel Blocker Overdose. Pediatric Cardiac Intensive Care Society Annual Meeting December 2022.

Mauracher AA, Conrey P, Sayed S, Campos JS, Hay C, Lindell RB, Bergerson J, Degragne M, Takanohashi A, Vargas-Hernandez A, Vanderver AL, Leiding JW, Forbes L, Holland S, Freeman A, Henrickson SE: Altered STAT1 signaling yields CD8+ T cell dysfunction in Inborn Errors of Immunity. 20th Biennial Meeting of The European Society for Immunodeficiencies October 2022.

Diorio C, Shraim R, Myers RM, Aplenc R, Banwell B, Bassiri H, Burudpakdee C, Behrens EM, Canna S, Chen F, DiNofia AM, Gill S, Gonzalez VE, Lambert MP, Leahy AB, Levine BL, Lindell RB, Maude SL, McGuire J, Newman H, Perrazelli J, Seif AE, Lacey SF, June CH, Barrett D, Grupp SA, Teachey DT: Comprehensive Proteomic Profiling to Identify Biomarkers and Therapeutic Targets for Immune Effector Cell Associated Neurotoxicity (ICANS) after Treatment with Chimeric Antigen Receptor T Cells. International Society of Pediatric Oncology Annual Meeting October 2022.

back to top
Last updated: 01/29/2024
The Trustees of the University of Pennsylvania